BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15684570)

  • 21. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats.
    Fujio M; Nakagawa T; Sekiya Y; Ozawa T; Suzuki Y; Minami M; Satoh M; Kaneko S
    Eur J Neurosci; 2005 Dec; 22(11):2744-54. PubMed ID: 16324108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychotomimetic-induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain.
    Hashimoto T; Kajii Y; Nishikawa T
    Eur J Neurosci; 1998 Nov; 10(11):3387-99. PubMed ID: 9824452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix-degrading enzymes tissue plasminogen activator and matrix metalloprotease-3 in the hypothalamo-neurohypophysial system.
    Miyata S; Nakatani Y; Hayashi N; Nakashima T
    Brain Res; 2005 Oct; 1058(1-2):1-9. PubMed ID: 16150423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gabapentin blocks methamphetamine-induced sensitization and conditioned place preference via inhibition of α₂/δ-1 subunits of the voltage-gated calcium channels.
    Kurokawa K; Shibasaki M; Mizuno K; Ohkuma S
    Neuroscience; 2011 Mar; 176():328-35. PubMed ID: 21182903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BDNF stimulates expression, activity and release of tissue-type plasminogen activator in mouse cortical neurons.
    Fiumelli H; Jabaudon D; Magistretti PJ; Martin JL
    Eur J Neurosci; 1999 May; 11(5):1639-46. PubMed ID: 10215917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity.
    Guegan T; Cebrià JP; Maldonado R; Martin M
    Addict Biol; 2016 Nov; 21(6):1113-1126. PubMed ID: 26179931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
    Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
    Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urokinase-type plasminogen activator modulates mammalian circadian clock phase regulation in tissue-type plasminogen activator knockout mice.
    Cooper JM; Rastogi A; Krizo JA; Mintz EM; Prosser RA
    Eur J Neurosci; 2017 Mar; 45(6):805-815. PubMed ID: 27992087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue plasminogen activator is not involved in methamphetamine-induced neurotoxicity.
    Fukakusa A; Mizoguchi H; Koike H; Nabeshima T; Takuma K; Yamada K
    J Pharmacol Sci; 2008 Feb; 106(2):321-4. PubMed ID: 18277051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue plasminogen activator modulates the cellular and behavioral response to cocaine.
    Maiya R; Zhou Y; Norris EH; Kreek MJ; Strickland S
    Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1983-8. PubMed ID: 19181855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental stimulation changes tissue-type plasminogen activator activity in the adult mouse hippocampus.
    Horii-Hayashi N; Yoshikawa M; Matsusue Y; Ishizaka S; Nishi M; Wanaka A
    Neurochem Int; 2011 Jan; 58(1):1-4. PubMed ID: 20974200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dynamics and functional analysis of cytokines/proteinases with drug dependence].
    Yamada K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Nov; 28(5-6):195-201. PubMed ID: 19108506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of tissue plasminogen activator/plasminogen activator inhibitor-1 by hydrocortisone in rat primary astrocytes.
    Kwon KJ; Cho KS; Lee SH; Kim JN; Joo SH; Ryu JH; Ignarro LJ; Han SH; Shin CY
    J Neurosci Res; 2011 Jul; 89(7):1059-69. PubMed ID: 21412817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of urokinase-type plasminogen activator in the acquisition, expression and reinstatement of cocaine-induced conditioned-place preference.
    Bahi A; Kusnecov AW; Dreyer JL
    Behav Brain Res; 2008 Aug; 191(1):17-25. PubMed ID: 18436315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential.
    Gur-Wahnon D; Mizrachi T; Wald-Altman S; Al-Roof Higazi A; Brenner T
    J Autoimmun; 2014 Aug; 52():36-43. PubMed ID: 24423642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zinc-triggered induction of tissue plasminogen activator by brain-derived neurotrophic factor and metalloproteinases.
    Hwang IY; Sun ES; An JH; Im H; Lee SH; Lee JY; Han PL; Koh JY; Kim YH
    J Neurochem; 2011 Sep; 118(5):855-63. PubMed ID: 21615740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pro- and anti-addictive factors related to drug addiction].
    Yamada K; Nagai T; Nakajima A; Nabeshima T
    Nihon Yakurigaku Zasshi; 2005 Jul; 126(1):49-53. PubMed ID: 16141618
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting VGLUT2 in Mature Dopamine Neurons Decreases Mesoaccumbal Glutamatergic Transmission and Identifies a Role for Glutamate Co-release in Synaptic Plasticity by Increasing Baseline AMPA/NMDA Ratio.
    Papathanou M; Creed M; Dorst MC; Bimpisidis Z; Dumas S; Pettersson H; Bellone C; Silberberg G; Lüscher C; Wallén-Mackenzie Å
    Front Neural Circuits; 2018; 12():64. PubMed ID: 30210305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.
    Tsirka SE; Gualandris A; Amaral DG; Strickland S
    Nature; 1995 Sep; 377(6547):340-4. PubMed ID: 7566088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed and blunted induction of mRNA for tissue plasminogen activator in the brain of old rats following pentylenetetrazole-induced seizure activity.
    Popa-Wagner A; Fischer B; Platt D; Schmoll H; Kessler C
    J Gerontol A Biol Sci Med Sci; 2000 May; 55(5):B242-8. PubMed ID: 10819311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.